Impact of COVID-19 Outbreak on Global Rapid Influenza Diagnostic Tests Market - Drivers, Opportunities and Forecast Analysis to 2027
The Rapid Influenza Diagnostic Tests Market is estimated to be valued at USD 954.512 million by 2023 and is expected to register a CAGR of 7.80% during the forecast period 2018-2023

Rapid Influenza Diagnostic Tests Market 2021

The Rapid Influenza Diagnostic Tests Market is estimated to be valued at USD 954.512 million by 2023 and is expected to register a CAGR of 7.80% during the forecast period 2018-2023

Based on type of flu, the type A flu segment accounted for the largest market share in 2017, with a market value of USD 286.401 million. Influenza is a contagious respiratory infection caused by numerous flu viruses which affect the nose, throat, and lungs. As per the National Center for Biotechnology Information (NCBI) Report 2015, the influenza virus is responsible for seasonal epidemics affecting over 200,000 people with a death toll of approximately 30,000 to 50,000 patients every year in the US. As per the World Health Organization Report (WHO) 2017, influenza virus-infected 5% to 15% of the global population. As the prevalence of influenza is increasing, the number of diagnostic techniques such as immunochromatography-based rapid diagnostic test (RDT) and nucleic acid amplification test (NAAT) are used for the detection of influenza viruses in humans.

Access Full Report Details and Order this Premium Report @ https://www.marketresearchfuture.com/reports/influenza-diagnostics-market-3142

Major Key Players:

Market Research Future (MRFR) recognizes the following companies as the key players in the global Rapid Influenza Diagnostic Tests Market that includes Abbott, Analytik Jena AG, Becton, Dickinson and Company, Biocartis, bioMérieux Inc, Cepheid, DiaSorin S.p.A., F. Hoffmann-La Roche Ltd, GenMark Diagnostics, Inc., Luminex Corporation, Meridian Bioscience, Inc., Quidel Corporation, SA Scientific, Thermo Fisher Scientific Inc.

Regional Analysis

Geographically, the global Rapid Influenza Diagnostic Tests Market is segmented into the Americas, Europe, Asia-Pacific, and the Middle East & Africa. As per MRFR analysis, The Americas accounted for the largest market share of 38.0% in 2017, with a market value of USD 236.198 million, the market is expected to register a CAGR of 7.25% during the forecast period. Europe was the second-largest market in 2017. However, the market in Asia-Pacific is expected to register the highest CAGR.

Segmentation

The global Rapid Influenza Diagnostic Tests Market is segmented into type of flu, test type, and end user. On the basis of type of flu, the global Rapid Influenza Diagnostic Tests Market is further sub-segmented as type A flu, type B flu, and type C flu. The type A flu accounted for the market value of USD 286.401 million in 2017.

By test type, the global Rapid Influenza Diagnostic Tests Market has been sub-segmented into traditional diagnostic tests and molecular diagnostic tests. The test type segment accounted for the larger market share in 2017. However, the type of flu segment is expected to exhibit higher CAGR during the forecast period. Based on end user, the global Rapid Influenza Diagnostic Tests Market has been sub-segmented into hospitals & clinical laboratories and point-of-care testing.

NOTE: Our Team of Researchers are Studying Covid19 and its Impact on Various Industry Verticals and wherever required we will be considering Covid19 Footprints for Better Analysis of Market and Industries. Cordially get in Touch for More Details.

About Market Research Future

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

MRFR team have supreme objective to provide the optimum quality market research and intelligence services to our clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help to answer all their most important questions.

In order to stay updated with technology and work process of the industry, MRFR often plans & conducts meet with the industry experts and industrial visits for its research analyst members.

Contact Us:

Market Research Future (part of Wantstats Research and Media Private Limited),

99 Hudson Street, 5Th Floor,

New York, New York 10013

United States of America

+1 646 845 9312

Email: sales@marketresearchfuture.com